List of Tables
Table 1. Global Non-restriction Endonucleases Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 5kU
Table 3. Key Players of 25kU
Table 4. Key Players of 50kU
Table 5. Key Players of 100kU
Table 6. Key Players of >100kU
Table 7. Global Non-restriction Endonucleases Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Non-restriction Endonucleases Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Non-restriction Endonucleases Market Size by Region (US$ Million), 2021–2026
Table 10. Global Non-restriction Endonucleases Market Share by Region (2021–2026)
Table 11. Global Non-restriction Endonucleases Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Non-restriction Endonucleases Market Share by Region (2027–2032)
Table 13. Non-restriction Endonucleases Market Trends
Table 14. Non-restriction Endonucleases Market Drivers
Table 15. Non-restriction Endonucleases Market Challenges
Table 16. Non-restriction Endonucleases Market Restraints
Table 17. Global Non-restriction Endonucleases Revenue by Players (US$ Million), 2021–2026
Table 18. Global Non-restriction Endonucleases Market Share by Players (2021–2026)
Table 19. Global Top Non-restriction Endonucleases Players by Tier (Tier 1, Tier 2, and Tier 3), based on Non-restriction Endonucleases Revenue, 2025
Table 20. Ranking of Global Top Non-restriction Endonucleases Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Non-restriction Endonucleases Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Non-restriction Endonucleases, Headquarters and Area Served
Table 23. Global Key Players of Non-restriction Endonucleases, Products and Applications
Table 24. Global Key Players of Non-restriction Endonucleases, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Non-restriction Endonucleases Market Size by Type (US$ Million), 2021–2026
Table 27. Global Non-restriction Endonucleases Revenue Market Share by Type (2021–2026)
Table 28. Global Non-restriction Endonucleases Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Non-restriction Endonucleases Revenue Market Share by Type (2027–2032)
Table 30. Global Non-restriction Endonucleases Market Size by Application (US$ Million), 2021–2026
Table 31. Global Non-restriction Endonucleases Revenue Market Share by Application (2021–2026)
Table 32. Global Non-restriction Endonucleases Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Non-restriction Endonucleases Revenue Market Share by Application (2027–2032)
Table 34. North America Non-restriction Endonucleases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Non-restriction Endonucleases Market Size by Country (US$ Million), 2021–2026
Table 36. North America Non-restriction Endonucleases Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Non-restriction Endonucleases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Non-restriction Endonucleases Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Non-restriction Endonucleases Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Non-restriction Endonucleases Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Non-restriction Endonucleases Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Non-restriction Endonucleases Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Non-restriction Endonucleases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Non-restriction Endonucleases Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Non-restriction Endonucleases Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Non-restriction Endonucleases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Non-restriction Endonucleases Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Non-restriction Endonucleases Market Size by Country (US$ Million), 2027–2032
Table 49. Thermo Fisher Scientific Inc. Company Details
Table 50. Thermo Fisher Scientific Inc. Business Overview
Table 51. Thermo Fisher Scientific Inc. Non-restriction Endonucleases Product
Table 52. Thermo Fisher Scientific Inc. Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 53. Thermo Fisher Scientific Inc. Recent Development
Table 54. RayBiotech, Inc. Company Details
Table 55. RayBiotech, Inc. Business Overview
Table 56. RayBiotech, Inc. Non-restriction Endonucleases Product
Table 57. RayBiotech, Inc. Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 58. RayBiotech, Inc. Recent Development
Table 59. TransGen Biotech Company Details
Table 60. TransGen Biotech Business Overview
Table 61. TransGen Biotech Non-restriction Endonucleases Product
Table 62. TransGen Biotech Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 63. TransGen Biotech Recent Development
Table 64. AbMole BioScience Company Details
Table 65. AbMole BioScience Business Overview
Table 66. AbMole BioScience Non-restriction Endonucleases Product
Table 67. AbMole BioScience Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 68. AbMole BioScience Recent Development
Table 69. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Details
Table 70. Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
Table 71. Yisheng Biotechnology (Shanghai) Co., Ltd. Non-restriction Endonucleases Product
Table 72. Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 73. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
Table 74. GenScript Company Details
Table 75. GenScript Business Overview
Table 76. GenScript Non-restriction Endonucleases Product
Table 77. GenScript Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 78. GenScript Recent Development
Table 79. Shanghai Biyuntian Biotechnology Co., Ltd. Company Details
Table 80. Shanghai Biyuntian Biotechnology Co., Ltd. Business Overview
Table 81. Shanghai Biyuntian Biotechnology Co., Ltd. Non-restriction Endonucleases Product
Table 82. Shanghai Biyuntian Biotechnology Co., Ltd. Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 83. Shanghai Biyuntian Biotechnology Co., Ltd. Recent Development
Table 84. KACTUS Company Details
Table 85. KACTUS Business Overview
Table 86. KACTUS Non-restriction Endonucleases Product
Table 87. KACTUS Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 88. KACTUS Recent Development
Table 89. Shanghai Zhudian Biotechnology Co., Ltd. Company Details
Table 90. Shanghai Zhudian Biotechnology Co., Ltd. Business Overview
Table 91. Shanghai Zhudian Biotechnology Co., Ltd. Non-restriction Endonucleases Product
Table 92. Shanghai Zhudian Biotechnology Co., Ltd. Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 93. Shanghai Zhudian Biotechnology Co., Ltd. Recent Development
Table 94. ACROBiosystems Group Company Details
Table 95. ACROBiosystems Group Business Overview
Table 96. ACROBiosystems Group Non-restriction Endonucleases Product
Table 97. ACROBiosystems Group Revenue in Non-restriction Endonucleases Business (US$ Million), 2021–2026
Table 98. ACROBiosystems Group Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Non-restriction Endonucleases Picture
Figure 2. Global Non-restriction Endonucleases Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Non-restriction Endonucleases Market Share by Type: 2025 vs 2032
Figure 4. 5kU Features
Figure 5. 25kU Features
Figure 6. 50kU Features
Figure 7. 100kU Features
Figure 8. >100kU Features
Figure 9. Global Non-restriction Endonucleases Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Non-restriction Endonucleases Market Share by Application: 2025 vs 2032
Figure 11. Biological Laboratory Case Studies
Figure 12. University Research Room Case Studies
Figure 13. Others Case Studies
Figure 14. Non-restriction Endonucleases Report Years Considered
Figure 15. Global Non-restriction Endonucleases Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Non-restriction Endonucleases Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Non-restriction Endonucleases Market Share by Region: 2025 vs 2032
Figure 18. Global Non-restriction Endonucleases Market Share by Players in 2025
Figure 19. Global Non-restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Non-restriction Endonucleases Revenue in 2025
Figure 21. North America Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Non-restriction Endonucleases Market Share by Country (2021–2032)
Figure 23. United States Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Non-restriction Endonucleases Market Share by Country (2021–2032)
Figure 27. Germany Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Non-restriction Endonucleases Market Share by Region (2021–2032)
Figure 35. China Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Non-restriction Endonucleases Market Share by Country (2021–2032)
Figure 43. Mexico Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Non-restriction Endonucleases Market Share by Country (2021–2032)
Figure 47. Israel Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Non-restriction Endonucleases Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 51. RayBiotech, Inc. Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 52. TransGen Biotech Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 53. AbMole BioScience Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 54. Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 55. GenScript Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 56. Shanghai Biyuntian Biotechnology Co., Ltd. Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 57. KACTUS Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 58. Shanghai Zhudian Biotechnology Co., Ltd. Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 59. ACROBiosystems Group Revenue Growth Rate in Non-restriction Endonucleases Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed